Techila has enabled finding a potential novel cancer drug target. The research will be presented by Tarmo Äijö in his International Symposium on Biopharmaceutical Statistics presentation ”Unraveling cell-type specific signaling pathway models using a dynamical model with a nonparametric and probabilistic extensions using high-performance computing”.
Without Techila, I would be still in my lab, waiting for the results. The method that helped me to unravel the interesting new aspects in the cell signaling in a in a hepatocellular carcinoma cell line would have taken 6 months. With Techila, I was able to complete the data analysis in a couple of hours. This provided my research a great competitive advantage.